Hospira Announces Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose. Preservative-Free, Due To Particulate Matter

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Hospira Announces Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose. Preservative-Free, Due To Particulate Matter

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Hospira Announces Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose. Preservative-Free, Due To Particulate Matter

10/17/2014 05:02 PM EDT

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary recall of one lot of 1% Lidocaine HCI for Injection, USP, 10 mg per mL, 30 mL Single-dose, Preservative-Free (NDC 0409-4279-02; Lot 40-316-DK, Expiry 1APRIL2016) to the user level due to a confirmed customer report of particulate in a single unit. Hospira has identified the particulate as a human hair, embedded in and attached to a pinched area of the stopper.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420